Insights from the front line of investment readiness, sourcing and execution.
Network access was long considered a competitive advantage in venture capital — that advantage has been commoditised.
Read article → 3 May 2026Strong technology alone does not make a DeepTech company investable.
Read article → 23 April 2026Most deep tech ventures don’t fail because the technology doesn’t work. They fail because there’s no structured path from scientific breakthrough to investment-ready company. A continent rich in scientific talent, university spinoffs, and proprietary IP keeps watching its best technologies stall in endless pre-commercial cycles — or disappear entirely. At 2B Labs, we’ve built our…
Read article → 3 April 2026One of the most persistent misconceptions in HealthTech is assuming that strong science naturally leads to scalable growth.
Read article → 3 March 2026One of the biggest structural mistakes in DeepTech investing is applying software-style scaling assumptions to ClimateTech.
Read article →